News

C3 Scientific Conference 2018

On September 12 – 13, 2018, Coalition to Cure Calpain 3 hosted the “C3 Scientific Conference” in Arlington, Virginia.

In attendance were prominent neuromuscular clinicians, world renowned research scientists from academia and industry, and  representatives from various funding agencies. This included C3’s Scientific Advisory Board and C3 grant recipients.

The goal of the conference was to gather key experts for scientific discussion focused around increasing our understanding of LGMD2A and preparing for future clinical trials in order to accelerate the development of a therapy for this disease.

The topics of the sessions included:
• Pre-clinical models for LGMD2A
• Registries and genetic testing
• Outcomes Assessments and biomarkers
• Muscle building
• Gene therapy and gene editing

To learn more about Coalition to Cure Calpain 3 and the research we are funding to find a cure and treatment for LGMD2A/Calpainopathy or to donate to support our efforts, please visit us.

Recent Posts

  • New Research Alert! "The Energy Switch"

    A new paper, “CaMKIIβ Signaling drives expression of metabolic and stress response genes in skeletal muscle, and its loss contributes to the LGMDR1 phenotype,” was recently published in the journal Human Molecular Genetics. It was authored by a multi-institutional group led by Dr. Melissa Spencer, C3 Scientific Advisory Board Chair and Professor of Neurology and... Read More
    Jennifer Levy Research Updates

  • C3 on Capitol Hill: LGMD Day on the Hill 2026

    C3 was proudly represented in Washington, D.C. at the 2026 LGMD Day on the Hill, hosted by The Speak Foundation. C3 Advocacy Chair Melina Garza was selected as a 2026 delegate and had the privilege of leading the Texas and North Carolina delegation through a packed day of advocacy on Capitol Hill. The day began... Read More
    Michele Wrubel Advocacy